Le Lézard
Classified in: Health
Subjects: SVY, MAT

Study Finds Lotus Vaping Technologies' Flavored E-Liquids Reduce Smokers' Cigarettes Per Day at Significantly Higher Rate Than Tobacco Flavor


A rigorous three-month longitudinal cohort study of several of flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

BOISE, Idaho, Nov. 21, 2023 /PRNewswire/ -- Lotus Vaping Technologies, LLC, a Boise, Idaho-based manufacturer of bottled e-liquids for use in electronic nicotine delivery systems ("ENDS") or e-cigarettes, announced today that a rigorous three-month longitudinal cohort study of several of its Freenomstm branded flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

The three-month study conducted from March 2023 to August 2023 involved 451 randomly assigned participants who were cigarette smokers, 221 of which were assigned to a control group that used only tobacco-flavored e-liquid, and 230 of which were assigned to a group that could use any of five different non-tobacco flavored bottled e-liquids, including Lotus's proprietary Bluenomenomtm, Stranomenontm, X2 Cactus Jackfruit, and White Peach Raspberry flavors.

At the end of three months, the average number of cigarettes smoked per day ("CPD") by the tobacco-flavored control group was reduced from 12.51 to 9.54, for a 23.72% reduction, while for the flavored e-liquid group, the average CPD was reduced from 11.70 to 6.88, for a 41.25% reduction.  The reduction in cigarettes smoked per day was thus 73.9% greater for the flavored group than the tobacco-flavored group. The study results also demonstrated statistically significant differences between several of Lotus's flavored e-liquids when compared head-to-head against tobacco-flavored e-liquids with respect to CPD reduction.

Additionally, a full 14.3% of study participants in the flavored group had quit smoking cigarettes altogether by the end of the third month?a rate that is substantially higher than that typically reported for FDA-approved nicotine replacement therapy products (9.0%).

Lotus's Director of Sales, Mike Larsen stated, "We are very excited about these study results. This study demonstrates what users of our products have known anecdotally for a long time?flavored e-liquids are more effective than tobacco flavor at promoting cigarette smoking reduction and cessation. The FDA has been asking for this data?we hope it will now take it into consideration when reviewing our premarket tobacco product applications and grant our flavored products the marketing authorizations that they deserve."

About Lotus Vaping Technologies, LLC ? Creator of Nomenonstm E-Liquids

Established in 2013, Lotus is a leading manufacturer and wholesaler of premium e-liquids in the United States providing a diverse range of vapor products for sale to adult consumers that satisfy a wide variety of consumer preferences and serve as alternatives to combustible cigarettes. Lotus is committed to responsible manufacturing processes and utilizes only the highest standards in its e-liquid production.

Media Contact:
Mike Larsen
[email protected]

SOURCE Lotus Vaping Technologies, LLC


These press releases may also interest you

at 16:05
Tilray Brands, Inc. ("Tilray" or the "Company") , a leading global lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its fourth quarter and full fiscal year ended May 31, 2024 on July...

at 16:00
Fitch Ratings has affirmed its "A" (Strong) Insurer Financial Strength ratings for The Doctors Company, the nation's largest physician-owned medical malpractice insurer and part of TDC Group. The outlook of these ratings is "Stable."...

at 15:47
Abilene Christian University Bachelor of Science in Nursing students achieved a 100% pass rate for the National Council Licensure Exam for Registered Nurses national licensing exam in 2023, one of only six Texas BSN programs with a perfect pass rate....

at 15:30
The SOAR Community Network (SOAR) is proud to announce that our CEO, Mali Phonpadith, has been invited to speak at the National Children's Center, Inc. (NCC) Momentum Speaker's Series on July 26, 2024. This event, part of the NCC Intern and...

at 15:00
A coalition of freestanding behavioral health systems created the Texas Association of Behavioral Health Systems (TABHS) to serve as a unified voice that's mission is to help Texas policymakers identify solutions for addressing the state's behavioral...

at 14:55
Zai Lab Limited today announced that data published in the journal Cell demonstrate that neoadjuvant monotherapy with the poly (ADP-ribose) polymerase (PARP) inhibitor niraparib results in a high response rate and reshapes the tumor microenvironment...



News published on and distributed by: